97 related articles for article (PubMed ID: 18959266)
1. [Relationship between the expression of TrkB and anoikis resistance in nasopharyngeal carcinoma line].
Wen WS; Zhang Z; Xie Y; Yi X; Zhao WM; Xu ZW; Tang AZ; Huang GW
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 43(8):606-11. PubMed ID: 18959266
[TBL] [Abstract][Full Text] [Related]
2. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
3. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
4. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
[TBL] [Abstract][Full Text] [Related]
5. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
7. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
9. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
10. More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells.
Guo D; Hou X; Zhang H; Sun W; Zhu L; Liang J; Jiang X
J Exp Clin Cancer Res; 2011 Oct; 30(1):97. PubMed ID: 21999199
[TBL] [Abstract][Full Text] [Related]
11. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of tyrosine kinase receptors B in nasopharyngeal carcinoma patients].
Zhao W; Wen W; Zhang Z; Liao Z; Zhang S; Huang G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jun; 21(11):497-500. PubMed ID: 17674765
[TBL] [Abstract][Full Text] [Related]
14. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.
Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M
Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149
[TBL] [Abstract][Full Text] [Related]
16. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.
Perez-Pinera P; Hernandez T; García-Suárez O; de Carlos F; Germana A; Del Valle M; Astudillo A; Vega JA
Mol Cell Biochem; 2007 Jan; 295(1-2):19-26. PubMed ID: 16862449
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
18. [Study of brain-derived neurotrophic factor activating TrkB signaling cascades in the pathogenesis of multiple myeloma].
Sun CY; Hu Y; Guo T; Huang J; Zhang L; Chu ZB
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):238-42. PubMed ID: 18843977
[TBL] [Abstract][Full Text] [Related]
19. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
[TBL] [Abstract][Full Text] [Related]
20. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
